LENZ Therapeutics (LENZ) Financials: Revenue & Earnings
LENZ$3.13-0.01 -0.48%
$98.50M
Market Cap
—
P/E
—
Forward P/E
—
Score
LENZ Therapeutics (LENZ) Financials: Revenue & Earnings
LENZ price $3.13 -0.01 -0.48%
- Ticker
- LENZ
- Price
- $3.13
- Change
- -0.01 -0.48%
- Market cap ?
- $98.50M
- Beta ?
- 1.73
- Sector
- Healthcare
- Industry
- Biotechnology
Fair value
LENZ fair value $10.28. Price $3.13. Price is 70% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 1.72M. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 1.7). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 31.42M. Net debt -24.36M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Model uncertainty high for this stock
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-10-29 | — | -0.89 | — | 4.20M |
| 2026-08-11 | -1.02 | -1.05 | 5.49M | 2.38M |
| 2026-05-11 | -1.32 | -1.10 | 1.90M | 1.76M |
| 2026-03-24 | -1.16 | -0.91 | 1.59M | 3.08M |
| 2025-11-05 | -0.59 | -0.67 | 12.50M | 3.09M |
| 2025-07-30 | -0.53 | -0.58 | 5.00M | 714.29K |
| 2025-05-07 | -0.53 | -0.55 | — | 714.29K |
| 2025-03-19 | -0.46 | -0.42 | — | — |
| 2024-11-06 | -0.38 | -0.46 | — | — |
| 2024-08-14 | -0.40 | -0.49 | — | — |
| 2024-05-08 | -3.53 | -0.84 | — | — |
| 2024-02-27 | -0.40 | -0.13 | — | — |
| 2023-11-13 | -2.75 | -1.75 | — | — |
| 2023-08-14 | -6.79 | -6.79 | — | — |
| 2023-05-11 | -3.01 | -2.41 | — | — |
| 2023-03-20 | -3.08 | -3.45 | — | — |
| 2022-11-09 | -3.15 | -3.11 | — | — |
| 2022-08-11 | -3.36 | -3.44 | — | — |
| 2022-05-12 | -3.36 | -2.73 | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency Weekly.
Safety score 43/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. Dividend history is short. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| 2024-03-22 | $7.21 | 2024-03-18 | — | Weekly |
| 2024-03-15 | $7.21 | — | — | Weekly |
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-15 | RA CAPITAL MANAGEMENT, L.P. | Buy | 22.10K | $6.63 | 146.52K |
| 2026-06-15 | George Jeffrey P. | Buy | 22.10K | $6.63 | 146.52K |
| 2026-06-15 | Drapkin Kimberlee C | Buy | 22.10K | $6.63 | 146.52K |
| 2026-06-15 | MCCOLLUM JAMES W | Buy | 22.10K | $6.63 | 146.52K |
| 2026-06-15 | Thunen Shelley B | Buy | 22.10K | $6.63 | 146.52K |
| 2026-06-15 | Guerard Frederic | Buy | 22.10K | $6.63 | 146.52K |
| 2026-06-15 | Scheiner Zachary | Buy | 22.10K | $6.63 | 146.52K |
| 2026-03-27 | George Jeffrey P. | Buy | 5.59K | $8.92 | 49.89K |
| 2026-03-27 | Schimmelpennink Evert B. | Buy | 28.09K | $8.95 | 251.41K |
| 2026-03-27 | Chevallard Daniel R. | Buy | 7.50K | $8.57 | 64.28K |
| 2026-01-02 | Olsson Shawn | Buy | 84.20K | $16.00 | 1.35M |
| 2026-01-02 | Olsson Shawn | Buy | 14.00K | — | — |
| 2026-01-02 | Odrich Marc | Buy | 84.20K | $16.00 | 1.35M |
| 2026-01-02 | Odrich Marc | Buy | 14.00K | — | — |
| 2026-01-02 | Chevallard Daniel R. | Buy | 84.20K | $16.00 | 1.35M |
| 2026-01-02 | Chevallard Daniel R. | Buy | 14.00K | — | — |
| 2026-01-02 | Schimmelpennink Evert B. | Buy | 358.10K | $16.00 | 5.73M |
| 2025-11-17 | Olsson Shawn | Sell | 10.00K | $2.08 | 20.80K |
| 2025-11-17 | Olsson Shawn | Buy | 10.00K | $2.08 | 20.80K |
| 2025-11-17 | Olsson Shawn | Sell | 4.21K | $25.74 | 108.41K |
| 2025-11-17 | Olsson Shawn | Sell | 5.79K | $26.37 | 152.61K |
| 2025-11-07 | MCCOLLUM JAMES W | Buy | 10.50K | $22.79 | 239.28K |
| 2025-11-07 | Chevallard Daniel R. | Buy | 2.18K | $22.76 | 49.56K |
| 2025-11-07 | Chevallard Daniel R. | Buy | 20 | $22.71 | 454 |
| 2025-09-30 | Versant Venture Capital VI, L.P. | Sell | 49.70K | $45.35 | 2.25M |
| 2025-09-30 | Versant Venture Capital VI, L.P. | Sell | 83.07K | $46.41 | 3.85M |
| 2025-09-30 | Versant Venture Capital VI, L.P. | Sell | 177 | $47.01 | 8.32K |
| 2025-09-30 | Versant Venture Capital VI, L.P. | Sell | 34.41K | $45.35 | 1.56M |
| 2025-09-30 | Versant Venture Capital VI, L.P. | Sell | 57.50K | $46.41 | 2.67M |
| 2025-09-30 | Versant Venture Capital VI, L.P. | Sell | 123 | $47.01 | 5.78K |
| 2025-09-18 | Versant Venture Capital VI, L.P. | Sell | 49.48K | $41.59 | 2.06M |
| 2025-09-18 | Versant Venture Capital VI, L.P. | Sell | 40.91K | $43.00 | 1.76M |
| 2025-09-18 | Versant Venture Capital VI, L.P. | Sell | 268 | $43.30 | 11.60K |
| 2025-09-18 | Versant Venture Capital VI, L.P. | Sell | 24.37K | $41.59 | 1.01M |
| 2025-09-18 | Versant Venture Capital VI, L.P. | Sell | 20.15K | $43.00 | 866.44K |
| 2025-09-18 | Versant Venture Capital VI, L.P. | Sell | 132 | $43.30 | 5.72K |
| 2025-08-26 | Versant Venture Capital VI, L.P. | Sell | 43.98K | $38.97 | 1.71M |
| 2025-08-26 | Versant Venture Capital VI, L.P. | Sell | 3.46K | $39.50 | 136.88K |
| 2025-08-26 | Versant Venture Capital VI, L.P. | Sell | 21.66K | $38.97 | 844.22K |
| 2025-08-26 | Versant Venture Capital VI, L.P. | Sell | 1.71K | $39.50 | 67.43K |
| 2025-08-25 | Versant Venture Capital VI, L.P. | Sell | 50.27K | $39.53 | 1.99M |
| 2025-08-25 | Versant Venture Capital VI, L.P. | Sell | 2.15K | $39.92 | 85.79K |
| 2025-08-25 | Versant Venture Capital VI, L.P. | Sell | 24.76K | $39.53 | 978.65K |
| 2025-08-25 | Versant Venture Capital VI, L.P. | Sell | 1.06K | $39.92 | 42.24K |
| 2025-08-22 | Versant Venture Capital VI, L.P. | Sell | 20.49K | $40.03 | 820.33K |
| 2025-08-22 | Versant Venture Capital VI, L.P. | Sell | 5.67K | $40.59 | 230.06K |
| 2025-08-22 | Versant Venture Capital VI, L.P. | Sell | 10.08K | $40.03 | 403.34K |
| 2025-08-22 | Versant Venture Capital VI, L.P. | Sell | 2.81K | $40.59 | 114.02K |
| 2025-08-18 | Versant Venture Capital VI, L.P. | Sell | 30.63K | $38.56 | 1.18M |
| 2025-08-18 | Versant Venture Capital VI, L.P. | Sell | 15.09K | $38.56 | 581.69K |
| 2025-08-15 | Versant Venture Capital VI, L.P. | Sell | 145.05K | $39.50 | 5.73M |
| 2025-08-15 | Versant Venture Capital VI, L.P. | Sell | 69.95K | $39.50 | 2.76M |
| 2025-07-10 | Versant Venture Capital VI, L.P. | Sell | 191.38K | $34.00 | 6.51M |
| 2025-06-27 | Versant Venture Capital VI, L.P. | Sell | 200.00K | $30.46 | 6.09M |
| 2025-06-20 | Versant Venture Capital VI, L.P. | Sell | 133.92K | $30.25 | 4.05M |
| 2025-06-20 | Versant Venture Capital VI, L.P. | Sell | 100.88K | $30.35 | 3.06M |
| 2025-06-18 | Versant Venture Capital VI, L.P. | Sell | 100.00K | $29.95 | 3.00M |
| 2025-06-11 | RA CAPITAL MANAGEMENT, L.P. | Buy | 13.50K | $30.00 | 405.00K |
| 2025-06-11 | George Jeffrey P. | Buy | 13.50K | $30.00 | 405.00K |
| 2025-06-11 | Drapkin Kimberlee C | Buy | 13.50K | $30.00 | 405.00K |
| 2025-06-11 | Guerard Frederic | Buy | 13.50K | $30.00 | 405.00K |
| 2025-06-11 | Thunen Shelley B | Buy | 13.50K | $30.00 | 405.00K |
| 2025-06-11 | MCCOLLUM JAMES W | Buy | 13.50K | $30.00 | 405.00K |
| 2025-06-11 | Scheiner Zachary | Buy | 13.50K | $30.00 | 405.00K |
| 2025-06-10 | Versant Venture Capital VI, L.P. | Sell | 350.00K | $29.00 | 10.15M |
| 2025-04-09 | Olsson Shawn | Sell | 1.40K | $2.08 | 2.91K |
| 2025-04-09 | Olsson Shawn | Buy | 1.40K | $2.08 | 2.91K |
| 2025-03-07 | Schimmelpennink Evert B. | Sell | 4.20K | $1.04 | 4.37K |
| 2025-03-07 | Schimmelpennink Evert B. | Buy | 4.20K | $1.04 | 4.37K |
| 2025-01-09 | Olsson Shawn | Buy | 80.10K | $26.34 | 2.11M |
| 2025-01-09 | Odrich Marc | Buy | 80.10K | $26.34 | 2.11M |
| 2025-01-09 | Chevallard Daniel R. | Buy | 70.44K | $26.34 | 1.86M |
| 2025-01-09 | Schimmelpennink Evert B. | Buy | 279.10K | $26.34 | 7.35M |
| 2024-12-16 | Olsson Shawn | Sell | 3.33K | $2.08 | 6.93K |
| 2024-12-16 | Olsson Shawn | Buy | 3.33K | $2.08 | 6.93K |
| 2024-07-22 | Schimmelpennink Evert B. | Sell | 45.00K | $1.04 | 46.80K |
| 2024-07-22 | Schimmelpennink Evert B. | Buy | 45.00K | $1.04 | 46.80K |
| 2024-05-14 | Chevallard Daniel R. | Buy | 3.19K | $15.68 | 49.99K |
| 2024-05-13 | MCCOLLUM JAMES W | Buy | 31.33K | $15.99 | 501.09K |
| 2024-03-21 | Alpha Wave Ventures GP, Ltd | Other | 0 | — | — |
| 2024-03-21 | Alpha Wave Ventures GP, Ltd | Other | 0 | — | — |
| 2024-03-21 | RA CAPITAL MANAGEMENT, L.P. | Buy | 933.04K | $15.03 | 14.02M |
| 2024-03-21 | RA CAPITAL MANAGEMENT, L.P. | Buy | 2.39M | — | — |
| 2024-03-21 | RA CAPITAL MANAGEMENT, L.P. | Buy | 64.97K | $15.03 | 976.51K |
| 2024-03-21 | RA CAPITAL MANAGEMENT, L.P. | Buy | 694.75K | — | — |
| 2024-03-21 | RA CAPITAL MANAGEMENT, L.P. | Buy | 164.73K | — | — |
| 2024-03-21 | RA CAPITAL MANAGEMENT, L.P. | Buy | 54.58K | $10.64 | 580.75K |
| 2024-03-21 | RA CAPITAL MANAGEMENT, L.P. | Buy | 27.00K | $15.05 | 406.35K |
| 2024-03-21 | RA CAPITAL MANAGEMENT, L.P. | Buy | 10.58K | $10.64 | 112.57K |
| 2024-03-21 | RA CAPITAL MANAGEMENT, L.P. | Buy | 5.37K | $10.64 | 57.15K |
| 2024-03-21 | RA CAPITAL MANAGEMENT, L.P. | Other | 0 | — | — |
| 2024-03-21 | Thunen Shelley B | Buy | 27.00K | $15.05 | 406.35K |
| 2024-03-21 | MCCOLLUM JAMES W | Buy | 16.63K | $15.03 | 249.99K |
| 2024-03-21 | MCCOLLUM JAMES W | Buy | 477.60K | — | — |
| 2024-03-21 | MCCOLLUM JAMES W | Buy | 95.03K | — | — |
| 2024-03-21 | MCCOLLUM JAMES W | Buy | 27.00K | $15.05 | 406.35K |
| 2024-03-21 | MCCOLLUM JAMES W | Buy | 6.58K | $10.64 | 69.96K |
| 2024-03-21 | Guerard Frederic | Buy | 30.90K | $2.08 | 64.27K |
| 2024-03-21 | Guerard Frederic | Buy | 27.00K | $15.05 | 406.35K |
| 2024-03-21 | Guerard Frederic | Buy | 23.57K | $6.04 | 142.37K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 152, holders 0 vs prior quarter. Ownership 111.21%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 4.18M | 0 | 0.00% | 23.74M |
| ALPHA WAVE GLOBAL, LP | 3.61M | 0 | 0.00% | 20.52M |
| FMR LLC | 3.56M | -38.88K | -1.08% | 20.21M |
| VERSANT VENTURE MANAGEMENT, LLC | 2.66M | 0 | 0.00% | 15.09M |
| BLACKROCK, INC. | 2.29M | 315.30K | +15.95% | 13.02M |
| SQUAREPOINT OPS LLC | 1.75M | 240.60K | +15.97% | 9.92M |
| ABERDEEN GROUP PLC | 1.55M | 391.72K | +33.88% | 8.79M |
| MILLENNIUM MANAGEMENT LLC | 1.51M | 639.22K | +73.54% | 8.57M |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.10M | 56.57K | +5.43% | 6.24M |
| 72 INVESTMENT HOLDINGS, LLC | 1.02M | 0 | 0.00% | 5.78M |
| BLUE OWL CAPITAL HOLDINGS LP | 756.72K | 250.00K | +49.34% | 4.30M |
| C WORLDWIDE GROUP HOLDING A/S | 700.00K | 0 | 0.00% | 3.98M |
| GEODE CAPITAL MANAGEMENT, LLC | 564.66K | 40.09K | +7.64% | 3.21M |
| TREXQUANT INVESTMENT LP | 497.53K | 283.12K | +132.05% | 2.83M |
| MARSHALL WACE, LLP | 493.10K | 332.83K | +207.68% | 2.80M |
| QUBE RESEARCH & TECHNOLOGIES LTD | 482.19K | 482.19K | New | 2.74M |
| MORGAN STANLEY | 473.00K | -175.85K | -27.10% | 2.69M |
| PRIMECAP MANAGEMENT CO/CA/ | 472.20K | 0 | 0.00% | 2.68M |
| TANG CAPITAL MANAGEMENT LLC | 451.11K | 0 | 0.00% | 2.56M |
| ALYESKA INVESTMENT GROUP, L.P. | 438.88K | -24.61K | -5.31% | 2.49M |
| STATE STREET CORP | 406.67K | 4.45K | +1.11% | 2.31M |
| CITADEL ADVISORS LLC | 363.23K | 287.93K | +382.38% | 2.06M |
| TWO SIGMA INVESTMENTS, LP | 285.58K | -215.41K | -43.00% | 1.62M |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 257.46K | 0 | 0.00% | 1.46M |
| BANK OF AMERICA CORP /DE/ | 255.41K | -292.12K | -53.35% | 1.45M |
Earnings and financials
LENZ Therapeutics, Inc. (LENZ) trades at $3.13, with a market cap of $98.50M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn